Latest oppositions filed by Pohlman, Sandra M.

This table presents recent patent oppositions filed by Pohlman, Sandra M. against its competitors. It outlines key details of each case, including the patent title, filing date and the applicant. This information provides insights into the competitive landscape and highlights active disputes over patent grant within the industry.

Patent NumberTitleApplicantOpposition Date
EP4219687Methods For Isolating, Culturing, And Genetically Engineering Immune Cell Populations For Adoptive TherapyJUNO THERAPEUTICS, INC.Oct 29, 2024
EP3384049Methods Of Associating Genetic Variants With A Clinical Outcome In Patients Suffering From Age-Related Macular Degeneration Treated With Anti-VegfREGENERON PHARMACEUTICALS, INC.Apr 30, 2024
EP3597749Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of TranscriptionCHARPENTIER, EMMANUELLEApr 26, 2024
EP3911354Aav-Mediated Gene Therapy Restoring The Otoferlin GeneCENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)Apr 19, 2024
EP3733847Composition For Cleaving A Target Dna Comprising A Guide Rna Specific For The Target Dna And Cas Protein-Encoding Nucleic Acid Or Cas Protein, And Use ThereofTOOLGEN INCORPORATEDMar 1, 2023
EP3464373Use Of Anti-Pd-1 Antibody In The Treatment Of Patients With Colorectal CancerBRISTOL-MYERS SQUIBB COMPANYJul 26, 2022
EP3498734Combination Of A Pd-1 Antagonist And A Vegfr Inhibitor For Treating CancerMERCK SHARP & DOHME CORP.May 31, 2022
EP3401335Composition Comprising Antibody That Binds To Domain Ii Of Her2 And Acidic Variants ThereofGENENTECH, INC.Mar 22, 2022
EP3288980Treatment Of Pd-L1-Positive Melanoma Using An Anti-Pd-1 AntibodyBRISTOL-MYERS SQUIBB COMPANYDec 10, 2021
EP3330370Process For Cultivation Of Cho CellsNOVARTIS AGNov 24, 2021